SHL Medical and Kindeva Partner to Enhance Molly® Autoinjector Platform

Drug delivery companies — SHL Medical and Kindeva Drug Delivery — have formed a partnership to enhance SHL Medical’s Molly® autoinjector platform aimed at pharmaceutical and biotechnology companies.

The collaboration is expected to accelerate the delivery of self-injection therapies to improve patient experience by combining SHL’s expertise in advanced autoinjector technology with Kindeva’s capabilities in drug formulation, filling, and device assembly.

SHL Medical, a world-leading solutions provider of advanced drug delivery systems, and Kindeva Drug Delivery, a global CDMO and drug delivery expert, are partnering to offer fill finish and pre-validated final assembly services for SHL Medical’s Molly® autoinjector platform at Kindeva’s Bridgeton and Maryland Heights facilities.

Built on a modular platform technology, Molly® is a single-dose autoinjector developed to help pharma and biotech companies reduce initial investments and expedite development timelines.

This strategic partnership between SHL and Kindeva will enhance collaboration, resulting in faster project completion, streamlined communication, and efficient delivery of drug products.

Being one of only a few CDMOs who can address a full end-to-end range of services in one geographic location, Kindeva contributes to simplified supply chains.

Markus Puusepp, SHL Medical’s Chief Growth Officer, commented on the collaboration: “We are excited to partner with Kindeva to further enhance the capabilities of our Molly® autoinjector platform. This partnership will allow us to provide our customers with more efficient and comprehensive solutions, ultimately accelerating the delivery of innovative therapies to patients worldwide.”

Milton Boyer, CEO of Kindeva, said of the partnership: “Our collaboration with SHL Medical ensures that more patients will have access to treatments for a variety of conditions. By offering an integrated solution at our Bridgeton & Maryland Heights facilities, we can streamline project timelines, ensuring the timely, efficient, and safe delivery of drug products. I’m proud that our partnerships continue to have a positive impact on patients’ lives around the globe.”

For more, please find the original story source here.